Minnesota FOIA #P009464002

Implications of PARP1 in myelodysplastic syndromes and targeted therapy

This purchase order is a research grant awarded by the Twin Cities to Johns Hopkins University, Baltimore, MD, USA, for a project titled 'Implications of PARP1 in myelodysplastic syndromes and targeted therapy.' The contract amount is $180,175, and it was issued on October 14, 2022. The award involves a single line item for research related to PARP1 and targeted therapy, with Johns Hopkins University as the recipient and vendor. The award is a one-time transaction with no specified multi-year period. The procurement is categorized under research and development activities. The vendor's address is 720 Rutland Ave, Baltimore, MD 21205-2109. The project is likely to involve collaboration with medical or research institutions, but specific competitors are not listed.

Description

Implications of PARP1 in myelodysplastic syndromes and targeted therapy